HEADER OXIDOREDUCTASE 15-NOV-18 6I6F TITLE SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SEPIAPTERIN REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SPR; COMPND 5 EC: 1.1.1.153; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SPR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS SEPIAPTERIN-REDUCTASE, OXIDOREDUCTASE, PROTEROS BIOSTRUCTURES GMBH EXPDTA X-RAY DIFFRACTION AUTHOR J.ALEN,M.SCHADE,M.WAGENER,M.BLAESSE REVDAT 3 15-MAY-24 6I6F 1 REMARK REVDAT 2 24-JUL-19 6I6F 1 JRNL REVDAT 1 10-JUL-19 6I6F 0 JRNL AUTH J.ALEN,M.SCHADE,M.WAGENER,F.CHRISTIAN,S.NORDHOFF,B.MERLA, JRNL AUTH 2 T.R.DUNKERN,G.BAHRENBERG,P.RATCLIFFE JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL POTENT SEPIAPTERIN JRNL TITL 2 REDUCTASE INHIBITORS. JRNL REF J.MED.CHEM. V. 62 6391 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31244106 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00218 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 35807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 2044 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2646 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 137 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 161 REMARK 3 SOLVENT ATOMS : 206 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.56000 REMARK 3 B22 (A**2) : -0.72000 REMARK 3 B33 (A**2) : 0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.185 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.161 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.708 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4169 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4118 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5655 ; 1.552 ; 2.039 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9446 ; 1.178 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 542 ; 5.955 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 159 ;38.536 ;24.214 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 700 ;10.816 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;16.137 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 659 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4667 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 898 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2106 ; 2.618 ; 3.343 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2105 ; 2.618 ; 3.343 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2631 ; 3.507 ; 5.617 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2632 ; 3.506 ; 5.617 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2063 ; 3.404 ; 3.761 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2063 ; 3.399 ; 3.761 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3012 ; 4.886 ; 6.123 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4435 ; 6.310 ;30.840 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4414 ; 6.276 ;30.770 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6I6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200012897. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37878 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 64.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.02600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.11300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.00 %W/V PEG 3350, 0.10 M BIS-TRIS REMARK 280 PROP PH 6.50, 0.10 M NABR, VAPOR DIFFUSION, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.57700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.42700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.59700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.42700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.57700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.59700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 GLY A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 GLU A 57 REMARK 465 ARG A 58 REMARK 465 SER A 59 REMARK 465 LYS A 261 REMARK 465 MET B -14 REMARK 465 GLY B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 58 REMARK 465 LYS B 261 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 HIS A -7 CG ND1 CD2 CE1 NE2 REMARK 480 ARG A 62 CZ NH1 NH2 REMARK 480 ARG A 84 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 85 CD OE1 OE2 REMARK 480 ARG A 88 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 90 CG CD CE NZ REMARK 480 LYS A 140 NZ REMARK 480 LYS A 230 CD CE NZ REMARK 480 GLU B 45 CD OE1 OE2 REMARK 480 GLU B 57 CG CD OE1 OE2 REMARK 480 LYS B 109 CD CE NZ REMARK 480 LYS B 140 CE NZ REMARK 480 LYS B 220 CE NZ REMARK 480 GLU B 224 CG CD OE1 OE2 REMARK 480 LYS B 228 CD CE NZ REMARK 480 LYS B 235 CD CE NZ REMARK 480 GLN B 239 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 41 168.50 178.39 REMARK 500 LEU A 128 -61.45 -109.13 REMARK 500 SER A 156 -157.79 -92.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H4E A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 311 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 305 DBREF 6I6F A 1 261 UNP P35270 SPRE_HUMAN 1 261 DBREF 6I6F B 1 261 UNP P35270 SPRE_HUMAN 1 261 SEQADV 6I6F MET A -14 UNP P35270 INITIATING METHIONINE SEQADV 6I6F GLY A -13 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -12 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -11 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -10 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -9 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -8 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS A -7 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLU A -6 UNP P35270 EXPRESSION TAG SEQADV 6I6F ASN A -5 UNP P35270 EXPRESSION TAG SEQADV 6I6F LEU A -4 UNP P35270 EXPRESSION TAG SEQADV 6I6F TYR A -3 UNP P35270 EXPRESSION TAG SEQADV 6I6F PHE A -2 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLN A -1 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLY A 0 UNP P35270 EXPRESSION TAG SEQADV 6I6F MET B -14 UNP P35270 INITIATING METHIONINE SEQADV 6I6F GLY B -13 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -12 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -11 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -10 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -9 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -8 UNP P35270 EXPRESSION TAG SEQADV 6I6F HIS B -7 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLU B -6 UNP P35270 EXPRESSION TAG SEQADV 6I6F ASN B -5 UNP P35270 EXPRESSION TAG SEQADV 6I6F LEU B -4 UNP P35270 EXPRESSION TAG SEQADV 6I6F TYR B -3 UNP P35270 EXPRESSION TAG SEQADV 6I6F PHE B -2 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLN B -1 UNP P35270 EXPRESSION TAG SEQADV 6I6F GLY B 0 UNP P35270 EXPRESSION TAG SEQRES 1 A 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU SEQRES 3 A 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA SEQRES 4 A 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU SEQRES 5 A 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU SEQRES 6 A 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL SEQRES 7 A 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU SEQRES 8 A 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO SEQRES 9 A 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY SEQRES 10 A 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER SEQRES 11 A 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU SEQRES 12 A 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA SEQRES 13 A 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN SEQRES 14 A 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP SEQRES 15 A 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU SEQRES 16 A 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL SEQRES 17 A 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN SEQRES 18 A 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG SEQRES 19 A 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL SEQRES 20 A 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU SEQRES 21 A 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE SEQRES 22 A 276 TYR ASP LYS SEQRES 1 B 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 B 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU SEQRES 3 B 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA SEQRES 4 B 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU SEQRES 5 B 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU SEQRES 6 B 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL SEQRES 7 B 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU SEQRES 8 B 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO SEQRES 9 B 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY SEQRES 10 B 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER SEQRES 11 B 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU SEQRES 12 B 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA SEQRES 13 B 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN SEQRES 14 B 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP SEQRES 15 B 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU SEQRES 16 B 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL SEQRES 17 B 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN SEQRES 18 B 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG SEQRES 19 B 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL SEQRES 20 B 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU SEQRES 21 B 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE SEQRES 22 B 276 TYR ASP LYS HET NAP A 301 48 HET H4E A 302 13 HET EDO A 303 4 HET EDO A 304 4 HET EDO A 305 4 HET EDO A 306 4 HET EDO A 307 4 HET EDO A 308 4 HET EDO A 309 4 HET EDO A 310 4 HET EDO A 311 4 HET NAP B 301 48 HET EDO B 302 4 HET EDO B 303 4 HET EDO B 304 4 HET EDO B 305 4 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM H4E ETHYL 4-AZANYL-3-BROMANYL-BENZOATE HETNAM EDO 1,2-ETHANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 H4E C9 H10 BR N O2 FORMUL 5 EDO 13(C2 H6 O2) FORMUL 19 HOH *206(H2 O) HELIX 1 AA1 HIS A -7 GLN A -1 5 7 HELIX 2 AA2 ARG A 17 LEU A 30 1 14 HELIX 3 AA3 ASN A 43 ALA A 56 1 14 HELIX 4 AA4 ALA A 72 GLU A 85 1 14 HELIX 5 AA5 GLY A 110 LEU A 114 5 5 HELIX 6 AA6 ASP A 116 LEU A 128 1 13 HELIX 7 AA7 LEU A 128 PHE A 142 1 15 HELIX 8 AA8 SER A 157 LEU A 161 5 5 HELIX 9 AA9 TRP A 167 GLU A 188 1 22 HELIX 10 AB1 THR A 203 SER A 213 1 11 HELIX 11 AB2 ASP A 215 LYS A 228 1 14 HELIX 12 AB3 ASP A 233 ASP A 248 1 16 HELIX 13 AB4 ARG B 17 LEU B 30 1 14 HELIX 14 AB5 ASN B 43 GLU B 57 1 15 HELIX 15 AB6 ALA B 72 GLU B 85 1 14 HELIX 16 AB7 GLY B 110 LEU B 114 5 5 HELIX 17 AB8 ASP B 116 LEU B 128 1 13 HELIX 18 AB9 LEU B 128 PHE B 142 1 15 HELIX 19 AC1 SER B 157 LEU B 161 5 5 HELIX 20 AC2 TRP B 167 GLU B 188 1 22 HELIX 21 AC3 THR B 203 SER B 213 1 11 HELIX 22 AC4 ASP B 215 LYS B 228 1 14 HELIX 23 AC5 ASP B 233 ASP B 248 1 16 SHEET 1 AA1 7 ARG A 62 PRO A 67 0 SHEET 2 AA1 7 VAL A 36 ALA A 41 1 N LEU A 39 O VAL A 64 SHEET 3 AA1 7 ALA A 8 LEU A 12 1 N CYS A 10 O VAL A 38 SHEET 4 AA1 7 ARG A 94 ASN A 99 1 O ILE A 98 N LEU A 11 SHEET 5 AA1 7 ASN A 149 ILE A 155 1 O THR A 151 N LEU A 95 SHEET 6 AA1 7 VAL A 191 ALA A 197 1 O ARG A 192 N ARG A 150 SHEET 7 AA1 7 ALA A 254 ASP A 257 1 O VAL A 256 N ALA A 197 SHEET 1 AA2 7 ARG B 62 PRO B 67 0 SHEET 2 AA2 7 VAL B 36 ALA B 41 1 N LEU B 37 O ARG B 62 SHEET 3 AA2 7 ALA B 8 THR B 13 1 N CYS B 10 O VAL B 38 SHEET 4 AA2 7 ARG B 94 ASN B 99 1 O ILE B 98 N LEU B 11 SHEET 5 AA2 7 ASN B 149 ILE B 155 1 O THR B 151 N LEU B 95 SHEET 6 AA2 7 VAL B 191 ALA B 197 1 O ARG B 192 N ARG B 150 SHEET 7 AA2 7 ALA B 254 ASP B 257 1 O VAL B 256 N ASN B 195 SITE 1 AC1 35 GLY A 14 SER A 16 ARG A 17 GLY A 18 SITE 2 AC1 35 PHE A 19 ALA A 41 ARG A 42 ASN A 43 SITE 3 AC1 35 ALA A 68 ASP A 69 LEU A 70 ASN A 100 SITE 4 AC1 35 ALA A 101 LEU A 126 ILE A 155 SER A 156 SITE 5 AC1 35 TYR A 170 LYS A 174 PRO A 198 GLY A 199 SITE 6 AC1 35 PRO A 200 LEU A 201 THR A 203 MET A 205 SITE 7 AC1 35 GLN A 206 H4E A 302 EDO A 308 HOH A 424 SITE 8 AC1 35 HOH A 428 HOH A 439 HOH A 451 HOH A 457 SITE 9 AC1 35 HOH A 462 HOH A 467 HOH A 472 SITE 1 AC2 5 SER A 157 TRP A 167 TYR A 170 GLN A 206 SITE 2 AC2 5 NAP A 301 SITE 1 AC3 5 SER A 103 LEU A 104 GLY A 105 LEU A 208 SITE 2 AC3 5 HOH A 457 SITE 1 AC4 3 ARG A 210 GLU A 211 HOH A 458 SITE 1 AC5 7 GLU A -6 GLY A 6 ARG A 7 SER A 32 SITE 2 AC5 7 GLN A 93 HOH A 408 GLN B 162 SITE 1 AC6 3 ALA A 254 HIS A 255 ASP A 260 SITE 1 AC7 5 GLY A 105 ASP A 106 GLN A 119 LEU A 169 SITE 2 AC7 5 HOH A 444 SITE 1 AC8 3 ARG A 17 ASP A 204 NAP A 301 SITE 1 AC9 3 ASP A 204 LEU A 208 HOH A 430 SITE 1 AD1 2 MET A 218 HOH A 449 SITE 1 AD2 6 SER A 115 ASP A 116 SER A 117 HOH A 429 SITE 2 AD2 6 GLU B 73 GLN B 77 SITE 1 AD3 32 GLY B 14 SER B 16 ARG B 17 GLY B 18 SITE 2 AD3 32 PHE B 19 ALA B 41 ARG B 42 ASN B 43 SITE 3 AD3 32 ALA B 68 ASP B 69 LEU B 70 ASN B 100 SITE 4 AD3 32 ALA B 101 GLY B 102 LEU B 126 ILE B 155 SITE 5 AD3 32 SER B 156 TYR B 170 LYS B 174 PRO B 198 SITE 6 AD3 32 GLY B 199 LEU B 201 THR B 203 MET B 205 SITE 7 AD3 32 GLN B 206 HOH B 407 HOH B 417 HOH B 420 SITE 8 AD3 32 HOH B 429 HOH B 436 HOH B 444 HOH B 449 SITE 1 AD4 3 ASP B 69 GLY B 71 ASN B 122 SITE 1 AD5 7 ALA A 52 GLU A 53 SER B 137 LYS B 140 SITE 2 AD5 7 ALA B 141 HOH B 413 HOH B 423 SITE 1 AD6 5 ASN A 121 LEU B 70 LEU B 76 ALA B 125 SITE 2 AD6 5 SER B 130 SITE 1 AD7 6 PRO B 33 ALA B 185 PRO B 189 LYS B 251 SITE 2 AD7 6 SER B 252 HOH B 409 CRYST1 59.154 77.194 114.854 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016905 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012954 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008707 0.00000